Literature DB >> 12673563

Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.

Barbara Guertl1, Manfred Ratschek, Dieter Harms, Ute Jaenig, Ivo Leuschner, Christopher Poremba, Gerald Hoefler.   

Abstract

Nephrogenic rests (NRs), putative precursor lesions of nephroblastomas (Wilms' tumors), are found in 25% to 40% of kidneys presenting with nephroblastomas. Nephroblastomas are clonal tumors that, according to a genetic multistep model, are thought to arise as subclonal proliferations from NRs by accumulating genetic alterations. Different candidate genes for the pathogenesis of nephroblastomas have been identified, including those at chromosomes 11p13 (WT1 gene), 11p15 (WT2 gene), and 16q (WT3 gene). We investigated clonality and loss of heterozygosity (LOH) at these loci in different subtypes of NR. After microdissection under microscopic control, we analyzed a highly polymorphic locus of the human androgen receptor gene (HUMARA) for nonrandom X-inactivation of genomic DNA using a methylation-sensitive restriction enzyme to investigate clonality. Out of 14 patients, we found that 1 case each of adenomatous and hyperplastic NR and 2 of 7 cases of sclerosing NR were monoclonal. Five patients were noninformative. We assessed LOH at chromosomes 11p13, 11p15, and 16q by analyzing polymorphic gene loci at these regions. One hyperplastic NR and the corresponding tumor showed LOH at 11p13 and 11p15; 1 sclerosing NR and the corresponding tumor exhibited LOH at chromosome 16q. We demonstrate for the first time that sclerosing NRs can exhibit genetic alterations found in nephroblastomas, namely monoclonality and LOH at the WT gene loci. The histological morphology is no different between NRs with these genetic alterations and NRs without them. We conclude that these genetic changes are early events in the multistep genetic pathogenesis of nephroblastomas; however, they do not seem to fully determine a malignant potential of NR. Copyright 2003, Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673563     DOI: 10.1053/hupa.2003.32

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Glypican 3 overexpression in primary and metastatic Wilms tumors.

Authors:  Maria Tretiakova; Debra L Zynger; Chunyan Luan; Nicole K Andeen; Laura S Finn; Masha Kocherginsky; Bin T Teh; Ximing J Yang
Journal:  Virchows Arch       Date:  2014-11-04       Impact factor: 4.064

2.  Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes.

Authors:  Barbara Guertl; Ivo Leuschner; Dieter Harms; Gerald Hoefler
Journal:  Virchows Arch       Date:  2006-05-20       Impact factor: 4.064

3.  Analyzing the gene expression profile of anaplastic histology Wilms' tumor with real-time polymerase chain reaction arrays.

Authors:  Jun Lu; Yan-Fang Tao; Zhi-Heng Li; Lan Cao; Shao-Yan Hu; Na-Na Wang; Xiao-Juan Du; Li-Chao Sun; Wen-Li Zhao; Pei-Fang Xiao; Fang Fang; Li-Xiao Xu; Yan-Hong Li; Gang Li; He Zhao; Jian Ni; Jian Wang; Xing Feng; Jian Pan
Journal:  Cancer Cell Int       Date:  2015-04-20       Impact factor: 5.722

4.  The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour.

Authors:  Ryuji Fukuzawa; Matthew R Anaka; Ian M Morison; Anthony E Reeve
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.